1.
Toi Y, Kimura Y, Domeki Y, Kawana S, Aiba T, Ono H, Asou M, Tsurumi K, Suzuki K, Shimizu H, Sugisaka J, Saito R, Terayama K, Kawashima Y, Nakamura A, Yamanda S, Honda Y, Sugawara S. Association of low body surface area with dose reduction and/or discontinuation of nintedanib in patients with idiopathic pulmonary fibrosis: a pilot study. Sarcoidosis vasculitis and diffuse lung disease [Internet]. 2019Mar.11 [cited 2019Sep.22];36(1):74-8. Available from: http://www.mattioli1885journals.com/index.php/sarcoidosis/article/view/7383